74 related articles for article (PubMed ID: 27631787)
1. Somatic mutations and clonal dynamics in healthy and cirrhotic human liver.
Brunner SF; Roberts ND; Wylie LA; Moore L; Aitken SJ; Davies SE; Sanders MA; Ellis P; Alder C; Hooks Y; Abascal F; Stratton MR; Martincorena I; Hoare M; Campbell PJ
Nature; 2019 Oct; 574(7779):538-542. PubMed ID: 31645727
[TBL] [Abstract][Full Text] [Related]
2. Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma.
Kacar Z; Slud E; Levy D; Candia J; Budhu A; Forgues M; Wu X; Raziuddin A; Tran B; Shetty J; Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Bhudhisawasdi V; Lertprasertsuke N; Auewarakul C; Sangrajrang S; Mahidol C; Ruchirawat M; Wang XW
Commun Biol; 2024 Mar; 7(1):383. PubMed ID: 38553628
[TBL] [Abstract][Full Text] [Related]
3. CScape-somatic: distinguishing driver and passenger point mutations in the cancer genome.
Rogers MF; Gaunt TR; Campbell C
Bioinformatics; 2021 Nov; 37(22):4298. PubMed ID: 34695181
[No Abstract] [Full Text] [Related]
4. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
[TBL] [Abstract][Full Text] [Related]
5. Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity.
Fernández-Rodríguez C; Rodríguez-Sevilla JJ; Fernández-Ibarrondo L; Sánchez-González B; Gibert J; Bento L; García JF; Sancho JM; Diez-Feijóo R; Camacho L; García-Retortillo M; Gimeno E; Colomo L; Gutiérrez A; Bellosillo B; Salar A
Blood Adv; 2022 Jan; 6(1):82-86. PubMed ID: 34649275
[TBL] [Abstract][Full Text] [Related]
6. Understanding genomics and the immune environment of penile cancer to improve therapy.
Aydin AM; Chahoud J; Adashek JJ; Azizi M; Magliocco A; Ross JS; Necchi A; Spiess PE
Nat Rev Urol; 2020 Oct; 17(10):555-570. PubMed ID: 32812000
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion.
Budzinska MA; Shackel NA; Urban S; Tu T
Emerg Microbes Infect; 2018 Aug; 7(1):142. PubMed ID: 30087321
[TBL] [Abstract][Full Text] [Related]
8. Cellular Genomic Sites of Hepatitis B Virus DNA Integration.
Budzinska MA; Shackel NA; Urban S; Tu T
Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30037029
[TBL] [Abstract][Full Text] [Related]
9. Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.
Marchi FA; Martins DC; Barros-Filho MC; Kuasne H; Busso Lopes AF; Brentani H; Trindade Filho JCS; Guimarães GC; Faria EF; Scapulatempo-Neto C; Lopes A; Rogatto SR
Sci Rep; 2017 Jul; 7(1):6707. PubMed ID: 28751665
[TBL] [Abstract][Full Text] [Related]
10. HBV DNA Integration: Molecular Mechanisms and Clinical Implications.
Tu T; Budzinska MA; Shackel NA; Urban S
Viruses; 2017 Apr; 9(4):. PubMed ID: 28394272
[TBL] [Abstract][Full Text] [Related]
11. Paediatric hepatocellular carcinoma due to somatic CTNNB1 and NFE2L2 mutations in the setting of inherited bi-allelic ABCB11 mutations.
Vilarinho S; Erson-Omay EZ; Harmanci AS; Morotti R; Carrion-Grant G; Baranoski J; Knisely AS; Ekong U; Emre S; Yasuno K; Bilguvar K; Günel M
J Hepatol; 2014 Nov; 61(5):1178-83. PubMed ID: 25016225
[TBL] [Abstract][Full Text] [Related]
12. The mutational landscape of hepatocellular carcinoma.
Lee JS
Clin Mol Hepatol; 2015 Sep; 21(3):220-9. PubMed ID: 26523267
[TBL] [Abstract][Full Text] [Related]
13. Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.
Kim SK; Marusawa H; Eso Y; Chiba T; Kudo M
Dig Dis; 2013; 31(5-6):454-8. PubMed ID: 24281020
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma.
Budzinska MA; Tu T; d'Avigdor WM; McCaughan GW; Luciani F; Shackel NA
PLoS One; 2016; 11(9):e0162586. PubMed ID: 27631787
[TBL] [Abstract][Full Text] [Related]
15. Whole genome sequencing of matched tumor, adjacent non-tumor tissues and corresponding normal blood samples of hepatocellular carcinoma patients revealed dynamic changes of the mutations profiles during hepatocarcinogenesis.
Mao R; Liu J; Liu G; Jin S; Xue Q; Ma L; Fu Y; Zhao N; Xing J; Li L; Qiu Y; Lin B
Oncotarget; 2017 Apr; 8(16):26185-26199. PubMed ID: 28412734
[TBL] [Abstract][Full Text] [Related]
16. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
